NEW YORK, USA – IDEA Pharma, the leading Path to Market Design practice in pharma/ biotech, is delighted to announce the appointment of Geoff Birkett as Vice President, US Client Development.
With over 30 years of strategic and operational experience in pharma, Geoff brings to IDEA a huge depth of knowledge across launch and in line growth brands, as well as early development products. He also brings a disruptive creative energy that has been key to his success in the industry.
Geoff launched many successful, market leading brands as a senior leader with Lilly, Lundbeck and AstraZeneca, where he held Executive/ President roles in UK/ US/ Germany/ S Africa and Global businesses. He was responsible for one of AZ’s biggest ever blockbusters, Seroquel. He has worked as a senior leader in Biotech in recent years, specializing in CNS/ Pain/ Addiction.
I'm excited to join IDEA Pharma at this time. IDEA have a proven track record of designing the best path to market strategies. It's not cookie cutter, it's clever, based on superior insight. Mike has assembled a great team - I look forward to working with them to take IDEA to the next level.
Pharma is exploding with possibility, and the need to disrupt traditional management consultancy has never been greater… I am so excited that our approach – senior talent who’ve deep hands-on experience, working directly with our clients – is attracting superstars like Geoff. Wanting to make a meaningful difference is a deep part of our ethos, and I know Geoff will look to improve on that success, making sure meaningful medicines continue to reach patients.– Mike Rea, CEO